http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016069884-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_18d92c46f60af8af24e262b67381d7eb |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2440-38 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57434 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate | 2015-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a66c8d070990888d28a7be3ec6c0b41 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8fd96d0c555fefdfa914ecc38d6d988 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1040c60196f1f4ca3fe4b4cf5c81c07c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53fcddb77028d4438e07743f98d04c0c |
| publicationDate | 2016-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2016069884-A1 |
| titleOfInvention | Biomarkers for distinguishing between aggressive prostate cancer and non-aggressive prostate cancer |
| abstract | The present invention relates to the field of biomarkers. More specifically, the present invention relates to biomarkers useful in diagnosing aggressive prostate cancer. In one embodiment, a method for identifying patients as having or likely to have aggressive prostate cancer comprises the steps of (a) performing an assay on a biological sample obtained from the patient to detect fucosylated prostate specific antigen (PSA), transmembrane prostate androgen-induced protein, kallikrein-2, lipid phosphate phosphohydrolase 3, heparan-sulfate 6-O-sulfotransferase, prostatic acid phosphatase (PAP), nuclear RNA export factor 2, and protein POF1B; and (b) identifying the patient as having or likely to have aggressive prostate cancer if there is a statistically significant difference in the levels of fucosylated PSA, transmembrane prostate androgen-induced protein, kallikrein-2, lipid phosphate phosphohydrolase 3, heparan-sulfate 6-O-sulfotransferase, PAP, nuclear RNA export factor 2, and protein POF1B as compared to corresponding levels in a control sample that correlates to non-aggressive prostate cancer. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022146527-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3676393-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11624750-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022072479-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109561993-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111148844-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2020264182-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3490514-B1 |
| priorityDate | 2014-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1433.